| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/01/2023 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 13.9k | $0.00 | $0 | | 06/01/2023 |
| 06/01/2023 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 27.8k | $1.11 | $30.8k | | 06/01/2023 |
| 12/16/2022 | CODEXIS, INC. | CDXS | Grant | Common Stock | 37.9k | $0.00 | $0 | | 12/16/2022 |
| 06/16/2022 | IMPEL PHARMACEUTICALS INC | IMPL | Grant | Stock Option (right to buy) | 12.8k | $8.65 | $110.6k | | 06/16/2022 |
| 06/01/2022 | SANGAMO THERAPEUTICS, INC | SGMO | Purchase | Common Stock | 5k | $3.60 | $18k | | 06/01/2022 |
| 07/11/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Grant | Stock Option (right to buy) | 11.5k | $9.96 | $114.5k | | 07/11/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Common Stock | 3.7k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Common Stock | 7.4k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (disposition) | Common Stock | 458 | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Common Stock | 8.8k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (disposition) | Common Stock | 1.7k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Common Stock | 271 | $13.50 | $3.7k | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Series A-1 Preferred Stock | 61.1k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Exercise (in-the-money or at-the-money) | Series A-2 Warrants | 13.8k | $8.19 | $112.7k | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Exercise (in-the-money or at-the-money) | Series A-2 Preferred Stock | 13.8k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Series A-2 Preferred Stock | 120.4k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Exercise (in-the-money or at-the-money) | Series C-1 Warrant | 47.3k | $8.66 | $409.3k | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Exercise (in-the-money or at-the-money) | Series C-1 Preferred Stock | 47.2k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | Series C-1 Preferred Stock | 144k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Conversion | 5% Convertible Note | 0 | $0.00 | $0 | | 04/27/2021 |
| 04/22/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (acquisition) | 5% Convertible Note due 2021 | 0 | $0.00 | $0 | | 04/22/2021 |
| 02/25/2021 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 8.2k | $0.00 | $0 | | 02/25/2021 |
| 02/25/2021 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 16.4k | $11.19 | $183.5k | | 02/25/2021 |
| 05/18/2020 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 10k | $0.00 | $0 | | 05/18/2020 |
| 05/18/2020 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 20k | $10.46 | $209.2k | | 05/18/2020 |
| 05/18/2020 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 15k | $10.46 | $156.9k | | 05/18/2020 |
| 05/18/2020 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 2.5k | $0.00 | $0 | | 05/18/2020 |
| 05/12/2020 | ACHIEVE LIFE SCIENCES, INC. | ACHV | Grant | Stock Option (right to buy) | 22k | $0.43 | $9.5k | | 05/12/2020 |
| 03/18/2020 | SANGAMO THERAPEUTICS, INC | SGMO | Purchase | Common Stock | 3k | $5.20 | $15.6k | | 03/18/2020 |
| 06/10/2019 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 2.5k | $0.00 | $0 | | 06/10/2019 |
| 06/10/2019 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 15k | $9.38 | $140.7k | | 06/10/2019 |
| 05/22/2019 | Armata Pharmaceuticals, Inc. | APHB | Grant | Stock Option (Right to Buy) | 27.4k | $3.15 | $86.3k | | 05/22/2019 |
| 05/14/2019 | ACHIEVE LIFE SCIENCES, INC. | ACHV | Grant | Stock Option (right to buy) | 7k | $4.02 | $28.1k | | 05/14/2019 |
| 11/14/2018 | SANGAMO THERAPEUTICS, INC | SGMO | Purchase | Common Stock | 2k | $9.00 | $18k | | 11/14/2018 |
| 09/20/2018 | ACHIEVE LIFE SCIENCES, INC. | ACHV | Grant | Stock Option (right to buy) | 12k | $2.56 | $30.7k | | 09/20/2018 |
|